Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 365556590 series 3448744
Content provided by NYU Langone Health Department of Psychiatry. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NYU Langone Health Department of Psychiatry or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dr. Alan Schatzberg is a Professor of Psychiatry and Behavioral Sciences at Stanford Medicine, and Director of the Stanford Mood Disorders Center. His research examines the biology and psychopharmacology of depressive disorders. An NYU School of Medicine alumnus, Dr. Schatzberg was President of the American Psychiatric Association from 2009-2010.
Topics:
- Ketamine and Esketamine (incl. mechanisms of action)
- Ketamine and obsessive-compulsive disorder
- Opioids
- Psychedelic medicine
For more information:
https://med.stanford.edu/profiles/alan-schatzberg
Visit our website for more Insights on Psychiatry.
Watch this episode on YouTube
Executive Producer: Jon Earle
33 episodes
))
